May 4th, 2017
•This protocol describes the in vitro comparison of two key functional characteristics of rituximab: target binding and complement-dependent cytotoxicity (CDC) induction. The methods were employed for a side-to-side comparison between reference rituximab and a rituximab biosimilar. These assays can be employed during biosimilar development or as a quality control in their production.
Tags
Related Videos
Human T Lymphocyte Isolation, Culture and Analysis of Migration In Vitro
Introducing Shear Stress in the Study of Bacterial Adhesion
Establishing a Liquid-covered Culture of Polarized Human Airway Epithelial Calu-3 Cells to Study Host Cell Response to Respiratory Pathogens In vitro
Total Protein Extraction and 2-D Gel Electrophoresis Methods for Burkholderia Species
A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity
Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved